Cancer Vaccines Market Anticipates Impressive Growth Trajectory at a CAGR of 36% During the Forecast Period (2026-2036) | DelveInsight
The growth of the cancer vaccine market is expected to be mainly driven by increasing incidence, rising awareness and access to treatment, and the emergence of novel therapies such as OSE2101 (OSE Immunotherapeutic), Intismeran autogene (Merck/Moderna Therapeutics), CYLEMBIO (IO102-IO103)...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- Společnost Huawei uvádí řešení Fintelligent AI Solution, které pomůže finančním institucím po celém světě naplnit heslo „Own Your AI, Own Your Intelligence"
- Industry Veteran Sloan Dean Launches AI Hospitality Group, the First AI-Native Hotel Operating Company
- TopWorkplaces.com Names Roth Staffing Companies a Winner of the United States Remote Work Top Workplaces 2026 Award
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →